ISCTM and ECNP | Posters & Presentations - Cambridge Cognition
We’re attending ISCTM 2025 and ECNP 38th Congress 2025 to share our latest research on CNS drug development, psychiatry, and cognitive neuroscience.| Cambridge Cognition
CTIS | Posters & Presentations Genentech, South San Francisco, CA, USA | 15th October 08:30am – 5:30pm PST We’re excited to announce that our team will be attending the 2nd Annual Clinical Trial Innovation Summit 2025 This years Clinical Trial Innovation Summit brings together global leaders driving the future of clinical research and we’re proud […] The post CTIS | Posters & Presentations appeared first on Cambridge Cognition.| Cambridge Cognition
We’re attending ISCTM 2025 and ECNP 38th Congress 2025 to share our latest research on CNS drug development, psychiatry, and cognitive neuroscience.| Cambridge Cognition
San Francisco VA offers new Alzheimer’s treatment to slow symptoms in Veterans. Innovative therapy provides hope and early intervention.| VA News
How Picture Description Tasks Can Help Track Cognitive Health Remotely Speech as a digital biomarker in clinical research Changes in how we speak—how quickly we talk, how often we pause, and the words we choose—can be early signs of cognitive decline. People with mild cognitive impairment (MCI) or dementia due to Alzheimer’s disease (AD) often […]| Cambridge Cognition
Cognition in The Blood (Biomarker) How do digital cognitive assessments relate to the Blood Plasma p-Tau217 in patients with Mild Cognitive Impairment (MCI)? Our latest research explores an exciting dataset with the AI–Mind Project, who have given us the opportunity to test the associations of our cognitive assessments alongside classic paper-and-pencil tests to levels of […] The post Cognition in The Blood (Biomarker) appeared first on Cambridge Cognition.| Cambridge Cognition
AAIC25 | Posters & Presentations Toronto, Canada | 27th – 31st July | Booth 1531 Unveiling Cutting-Edge Alzheimer’s & Dementia Research at AAIC 2025: A Sneak Peek at Our Latest Posters The Alzheimer’s Association International Conference (AAIC) is just around the corner, and we’re incredibly excited to share some of the latest research our team […] The post AAIC25 | Posters & Presentations appeared first on Cambridge Cognition.| Cambridge Cognition
In a new study, Nobel laureate David Baker and colleagues detail new methods for targeting undruggable "disordered" proteins.| STAT
Alzheimer’s disease and other forms of dementia profoundly impact millions of individuals and their families. Often diagnosed too late for effective intervention, these conditions highlight the critical need for early detection. Early screening trials for Alzheimer’s are emerging as a game-changing approach, offering hope for earlier intervention, innovative treatments, and a better quality of life. … Memory Loss and Alzheimer’s: How Early Screening Trials Could Change Lives Read More »| Princeton Medical Institute
Alzheimer’s and dementia are complex, progressive conditions that impact millions of individuals and their families around the world. In the pursuit of effective treatments, clinical trials play an essential role, driving advancements in care, expanding treatment options, and offering hope to those affected. Through rigorous testing and research, clinical trials not only pave the way … The Role of Clinical Trials in Advancing Alzheimer’s and Dementia Care Read More »| Princeton Medical Institute
